Log in

Relevant bibliographies by topics / Nicotine patches / Journal articles

To see the other types of publications on this topic, follow the link: Nicotine patches.

Journal articles on the topic 'Nicotine patches'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Nicotine patches.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

&NA;. "Nicotine patches." Inpharma Weekly &NA;, no. 1197 (1999): 7. http://dx.doi.org/10.2165/00128413-199911970-00012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Benowitz, N. L. "Nicotine patches." BMJ 310, no. 6991 (1995): 1409–10. http://dx.doi.org/10.1136/bmj.310.6991.1409b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Palmer, R., C. Scully, and D. H. Felix. "Nicotine, smoke and patches." British Dental Journal 200, no. 2 (2006): 65. http://dx.doi.org/10.1038/sj.bdj.4813187.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Jarvis, M. J., M. A. Russell, and C. Feyerabend. "Unlicensed nicotine skin patches." BMJ 306, no. 6878 (1993): 647. http://dx.doi.org/10.1136/bmj.306.6878.647.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Ueda, Kimiko. "Nicotine patches in Japan." Lancet 358, no. 9280 (2001): 512. http://dx.doi.org/10.1016/s0140-6736(01)05660-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Kalra, Roma, Shashi P. Singh, Juan C. Pena-Philippides, Raymond J. Langley, Seddigheh Razani-Boroujerdi, and Mohan L. Sopori. "Immunosuppressive and Anti-Inflammatory Effects of Nicotine Administered by Patch in an Animal Model." Clinical Diagnostic Laboratory Immunology 11, no. 3 (2004): 563–68. http://dx.doi.org/10.1128/cdli.11.3.563-568.2004.

Full text

Abstract:

ABSTRACT To study the immunological effects of nicotine, there are several rodent models for chronic nicotine administration. These models include subcutaneously implanted miniosmotic pumps, nicotine-spiked drinking water, and self-administration via jugular cannulae. Administration of nicotine via these routes affects the immune system. Smokers frequently use nicotine patches to quit smoking, and the immunological effects of nicotine patches are largely unknown. To determine whether the nicotine patch affects the immune system, nicotine patches were affixed daily onto the backs of Lewis rats

APA, Harvard, Vancouver, ISO, and other styles

7

Ruela, André Luís Morais, Eduardo Costa Figueiredo, Aline Gravinez Perissinato, Ana Carolina Zogbi Lima, Magali Benjamim Araújo, and Gislaine Ribeiro Pereira. "In vitro evaluation of transdermal nicotine delivery systems commercially available in Brazil." Brazilian Journal of Pharmaceutical Sciences 49, no. 3 (2013): 579–88. http://dx.doi.org/10.1590/s1984-82502013000300020.

Full text

Abstract:

The aim of this study was to develop and validate a method for evaluating the release and skin permeation from transdermal nicotine patches using the vertical diffusion cell (VDC). The VDC is an experimental apparatus employed in research, development, and the pharmaceutical field because it can simulate conditions closest to those established in clinical trials. Two transdermal nicotine delivery systems marketed in Brazil to release 14 mg over 24 hours were evaluated. Release studies were carried out using a regenerated cellulose dialysis membrane and permeation studies were carried out using

APA, Harvard, Vancouver, ISO, and other styles

8

Miller, Virginia M., W. Darrin Clouse, Britt H. Tonnessen, et al. "Time and dose effect of transdermal nicotine on endothelial function." American Journal of Physiology-Heart and Circulatory Physiology 279, no. 4 (2000): H1913—H1921. http://dx.doi.org/10.1152/ajpheart.2000.279.4.h1913.

Full text

Abstract:

Nicotine patches are available as an over-the-counter medication for aid in smoking cessation. This study was designed to determine how nicotine patch therapy over time and dose ranges used in smoking cessation programs in humans affects endothelium-dependent relaxations. Dogs were treated with nicotine patches (11, 22, or 44 mg/day) for 2 and 5 wk. Circulating nicotine and oxidized products of nitric oxide (NOx) were measured. Coronary arteries were prepared for measurement of isometric force and aortic endothelial cells were prepared for measurement of mRNA or NO synthase (NOS) activity. Cir

APA, Harvard, Vancouver, ISO, and other styles

9

Kang, Jeong Ho, and Sung Kgun Lee. "Progressive nicotine poisoning by multiple transdermal nicotine patches." Journal of Medicine and Life Science 18, no. 2 (2021): 31–34. http://dx.doi.org/10.22730/jmls.2021.18.2.31.

Full text

Abstract:

The pharmacokinetic properties of transdermal nicotine patches (TNPs) are different from those of other routes of nicotine administration; further, acute nicotine poisoning by TNPs may present with different clinical features. In the present report, we describe the case of a 23-year-old woman who was admitted to emergency department (ED) at Jeju National University Hospital with loss of consciousness. Five hours before the ED visit, she used multiple TNPs to attempt suicide. Initially, nausea and vomiting occurred, and the symptoms worsened over time. We immediately removed the TNPs, and the a

APA, Harvard, Vancouver, ISO, and other styles

10

&NA;. "Sustained nonsmoking after nicotine patches." Inpharma Weekly &NA;, no. 957 (1994): 14. http://dx.doi.org/10.2165/00128413-199409570-00032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Serra, Steven J., Julia A. Robertson, and John C. Carey. "Nicotine transdermal patches and pregnancy." American Journal of Obstetrics and Gynecology 183, no. 3 (2000): 778. http://dx.doi.org/10.1067/mob.2000.106978.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

&NA;. "More on nicotine transdermal patches." Inpharma Weekly &NA;, no. 837 (1992): 26. http://dx.doi.org/10.2165/00128413-199208370-00058.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

WISBORG, KIRSTEN, TINE BRINK HENRIKSEN, LONE BIRK JESPERSEN, and NIELS JØRGEN SECHER. "Nicotine Patches for Pregnant Smokers." Obstetrics & Gynecology 96, no. 6 (2000): 967–71. http://dx.doi.org/10.1097/00006250-200012000-00019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Marston, Geoffrey Michael, and Irene Dove Cormac. "Nicotine patches and paranoid psychosis." Irish Journal of Psychological Medicine 12, no. 2 (1995): 70–71. http://dx.doi.org/10.1017/s0790966700004262.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Lagrue, G., F. Verra, F. Lebargy, and Matthew Jackson. "Nicotine patches and vascular risks." Lancet 342, no. 8870 (1993): 564. http://dx.doi.org/10.1016/0140-6736(93)91698-l.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Campbell, I. A. "Nicotine patches in general practice." BMJ 306, no. 6888 (1993): 1284–85. http://dx.doi.org/10.1136/bmj.306.6888.1284.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Jameson, M. "Nicotine patches: up in smoke?" JAMA: The Journal of the American Medical Association 268, no. 13 (1992): 1686b—1686. http://dx.doi.org/10.1001/jama.268.13.1686b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Jameson, Mark. "Nicotine Patches: Up in Smoke?" JAMA: The Journal of the American Medical Association 268, no. 13 (1992): 1686. http://dx.doi.org/10.1001/jama.1992.03490130074032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Fiore, M. C. "Side effects of nicotine patches." JAMA: The Journal of the American Medical Association 270, no. 22 (1993): 2735b—2735. http://dx.doi.org/10.1001/jama.270.22.2735b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Gilbert, David G., Bryant M. Stone, and Norka E. Rabinovich. "Overdose symptoms and positive affect in never-established smokers are moderated by nicotine patch type: A between-subjects experimental investigation." F1000Research 11 (August 16, 2022): 937. http://dx.doi.org/10.12688/f1000research.124015.1.

Full text

Abstract:

Background: A growing number of studies have assessed the effects of acute nicotine on affect, cognition, and brain activity in never-established smokers in attempts to identify mechanisms by which nicotine promotes progression to dependence. However, these acute administration studies have not adequately addressed the problem of potential adverse side effects due to lack of tolerance, such as nausea, feelings of sickness, lightheadedness, and general negative affect and malaise – a term referred to as nicotine overdose events (NODEs). Thus, we report the first study to carefully characterize

APA, Harvard, Vancouver, ISO, and other styles

21

Sipe, Richard V. Sipe, David C. Buck, and Jeffrey O. Hollinger. "Nicotine Administration In Rabbits Using HabitrolR Nicotine Patches And Nicotine Nasal Spray." Clinical and Experimental Pharmacology and Physiology 27, no. 7 (2000): 480–82. http://dx.doi.org/10.1046/j.1440-1681.2000.03285.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Walker, Natalie, Marjolein Verbiest, Tomasz Kurdziel, et al. "Effectiveness and safety of nicotine patches combined with e-cigarettes (with and without nicotine) for smoking cessation: study protocol for a randomised controlled trial." BMJ Open 9, no. 2 (2019): e023659. http://dx.doi.org/10.1136/bmjopen-2018-023659.

Full text

Abstract:

IntroductionEvidence indicates e-cigarettes can help people quit smoking; however, more confirmatory trials are needed. To date, no trials have evaluated the effectiveness and safety of combining nicotine patches with e-cigarettes (with and without nicotine) for smoking cessation.Methods and analysisThis study is a pragmatic, three-arm, community-based, single-blind, randomised trial undertaken in New Zealand. Eligible participants are daily/non-daily smokers, aged ≥18 years, naive e-cigarette users and motivated to quit smoking in the next 2 weeks. Participants (n=1809), recruited using multi

APA, Harvard, Vancouver, ISO, and other styles

23

&NA;. "Nicotine patches: effectiveness related to genotype." Inpharma Weekly &NA;, no. 1431 (2004): 10. http://dx.doi.org/10.2165/00128413-200414310-00021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Woolf, A., K. Burkhart, T. Caraccio, and T. Litovitz. "Childhood Poisoning Involving Transdermal Nicotine Patches." PEDIATRICS 99, no. 5 (1997): e4-e4. http://dx.doi.org/10.1542/peds.99.5.e4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

&NA;. "Nicotine patches improve antipsychotic-induced akathisia." Inpharma Weekly &NA;, no. 1118 (1997): 17. http://dx.doi.org/10.2165/00128413-199711180-00036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

&NA;. "Nicotine patches improve antipsychotic-induced akathisia." Reactions Weekly &NA;, no. 682 (1997): 4. http://dx.doi.org/10.2165/00128415-199706820-00012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

&NA;. "GERD: remove nicotine patches at night." Inpharma Weekly &NA;, no. 994 (1995): 20. http://dx.doi.org/10.2165/00128413-199509940-00038.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

&NA;. "War declared against unlicensed nicotine patches." Inpharma Weekly &NA;, no. 880 (1993): 5–6. http://dx.doi.org/10.2165/00128413-199308800-00007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

&NA;. "Nicotine patches useful in general practice." Inpharma Weekly &NA;, no. 888 (1993): 14. http://dx.doi.org/10.2165/00128413-199308880-00028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Arnaot, M. R. "Nicotine patches may not be safe." BMJ 310, no. 6980 (1995): 663–64. http://dx.doi.org/10.1136/bmj.310.6980.663c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Lardi, C., S. Vogt, S. Pollak, and A. Thierauf. "Complex suicide with homemade nicotine patches." Forensic Science International 236 (March 2014): e14-e18. http://dx.doi.org/10.1016/j.forsciint.2013.12.017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

McAfee, Timothy A., Terry Bush, T. Mona Deprey, et al. "Nicotine Patches and Uninsured Quitline Callers." American Journal of Preventive Medicine 35, no. 2 (2008): 103–10. http://dx.doi.org/10.1016/j.amepre.2008.04.017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Dani, John A. "Nicotinic Receptor Activity Alters Synaptic Plasticity." Scientific World JOURNAL 1 (2001): 393–95. http://dx.doi.org/10.1100/tsw.2001.74.

Full text

Abstract:

Studies using specific agonists, antagonists, and lesions have shown that nicotinic cholinergic systems participate in attention, learning, and memory[1,2]. The nicotinic manipulations usually have the greatest influence on difficult tasks or on cognitively impaired subjects[2]. For example, Alzheimer's disease is characterized by a loss of cholinergic projections and nicotinic acetylcholine receptors (nAChRs) in the cortex and hippocampus[3]. Nicotine skin patches can improve learning rates and attention in Alzheimer's patients[4].

APA, Harvard, Vancouver, ISO, and other styles

34

Chulurks, Sorrawee, Kulpavee Jitapunkul, Sasimas Katanyutanon, Pisanu Toochinda та Luckhana Lawtrakul. "Stability Enhancement and Skin Permeation Application of Nicotine by Forming Inclusion Complex with β-Cyclodextrin and Methyl-β-Cyclodextrin". Scientia Pharmaceutica 89, № 4 (2021): 43. http://dx.doi.org/10.3390/scipharm89040043.

Full text

Abstract:

Nicotine is widely used in pharmaceutical industries, especially for smoking cessation in the form of transdermal patches. Nicotine gel in the patches has limitations from nicotine instability and high volatility. Thus, a nicotine preservation technique is needed. In this study, a nicotine encapsulation process using methyl-β-cyclodextrin (MβCD) is investigated and compared with β-cyclodextrin (βCD) to evaluate the preservation and skin permeation of nicotine. The M06-2X/6-31G(d,p) density functional theory calculations indicate a 1:1 host–guest molar ratio for the inclusion complex of nicotin

APA, Harvard, Vancouver, ISO, and other styles

35

Jimenez Ruiz, CA, S. Florez, A. Ramos, L. Ramos, S. Solano, and E. Fornies. "Smoking cessation with a 16 h nicotine patch: results in a group of hospital workers." European Respiratory Journal 10, no. 3 (1997): 573–75. http://dx.doi.org/10.1183/09031936.97.10030573.

Full text

Abstract:

As part of a programme for the implementation of a Smoking Control Policy in our hospital, an open study, without randomization, of 65 hospital workers, who wanted to give up smoking, was carried out. The characteristics of smoking in each subject were recorded. The Fagerstrom Questionnaire was used to measure the degree of dependence on nicotine. The treatment consisted of the daily use of 16 h nicotine patches for 12 weeks. During the first 4 weeks, the patches contained 15 mg of nicotine, for the second 4 weeks, 10 mg, and for the last 4 weeks 5 mg (per patch and day). Five visits were sche

APA, Harvard, Vancouver, ISO, and other styles

36

Vaishnavi, G. Karule, A. Kubde Jitendra, R. Hatwar Pooja, L. Bakal Ravindra, and S. Kathole Khushi. "Innovations in transdermal delivery: Exploring nicotine patches, microneedles and glucose monitoring technologies." GSC Biological and Pharmaceutical Sciences 29, no. 2 (2024): 341–55. https://doi.org/10.5281/zenodo.14760820.

Full text

Abstract:

Transdermal devices for delivering drugs have been invented in response to obstacles caused by oral administration of medications. An adhesive patch comprising medication that is applied topically for transferring a preset proportion of treatment through the skin and into the bloodstream is called a transdermal patch. The method of manufacturing for various transdermal application types, including matrix patches, is described in this review article. Addiction to cigarettes affects millions different people throughout. One example of a nicotine replacement treatment that is currently widely acc

APA, Harvard, Vancouver, ISO, and other styles

37

Kras, M., C. Stough, A. Scholey, C. Kure, and D. Camfield. "P.6.f.002 Hypericum perforatum, nicotine patches and combination hypericum perforatum/nicotine patches for smoking cessation." European Neuropsychopharmacology 20 (August 2010): S608—S609. http://dx.doi.org/10.1016/s0924-977x(10)70930-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Hajek, Peter, Dunja Przulj, Francesca Pesola, et al. "Electronic cigarettes versus nicotine patches for smoking cessation in pregnancy: a randomized controlled trial." Nature Medicine 28, no. 5 (2022): 958–64. http://dx.doi.org/10.1038/s41591-022-01808-0.

Full text

Abstract:

AbstractNicotine replacement therapy, in the form of nicotine patches, is commonly offered to pregnant women who smoke to help them to stop smoking, but this approach has limited efficacy in this population. Electronic cigarettes (e-cigarettes) are also used by pregnant women who smoke but their safety and efficacy in pregnancy are unknown. Here, we report the results of a randomized controlled trial in 1,140 participants comparing refillable e-cigarettes with nicotine patches. Pregnant women who smoked were randomized to e-cigarettes (n = 569) or nicotine patches (n = 571). In the unadjusted

APA, Harvard, Vancouver, ISO, and other styles

39

Lee, Cheol Min, Yu Jin Paek, Yoo Bin Seo, and Eon Sook Lee. "Pharmacotherapy guidelines for smoking cessation in primary healthcare clinics." Journal of the Korean Medical Association 67, no. 4 (2024): 230–39. http://dx.doi.org/10.5124/jkma.2024.67.4.230.

Full text

Abstract:

Background: Cigarette smoking is the leading preventable cause of death, with smoking cessation representing the most effective strategy to reduce the risk of smoking-related diseases. Pharmacotherapeutic interventions for smoking cessation such as nicotine replacement therapy, bupropion, and varenicline aim to manage the symptoms of nicotine cravings and withdrawal. Evidence-based practice guidelines for pharmacotherapy in smoking cessation have been recently developed in Korea.Current Concepts: Among the general population, varenicline is the recommended first-line therapy for smoking cessat

APA, Harvard, Vancouver, ISO, and other styles

40

&NA;. "Efficacy of Transdermal Nicotine Patches for Nicotine Replacement and Smoking Cessation." Nurse Practitioner 17, no. 7 (1992): 46???50. http://dx.doi.org/10.1097/00006205-199207000-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

&NA;. "Nicotine patches go OTC in the US." Inpharma Weekly &NA;, no. 1050 (1996): 22. http://dx.doi.org/10.2165/00128413-199610500-00052.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

&NA;. "Intensive intervention not necessary with nicotine patches." Inpharma Weekly &NA;, no. 906 (1993): 15. http://dx.doi.org/10.2165/00128413-199309060-00026.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

TONNESEN, PHILIP, JESPER NORREGAARD, URBAIN SAWE, and KARE SIMONSEN. "Recycling with nicotine patches in smoking cessation." Addiction 88, no. 4 (1993): 533–39. http://dx.doi.org/10.1111/j.1360-0443.1993.tb02060.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

&NA;. "Two more nicotine patches for the UK." Inpharma Weekly &NA;, no. 866 (1992): 22. http://dx.doi.org/10.2165/00128413-199208660-00051.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

JANCIN, BRUCE. "Nicotine Patches Appear Safe for CAD Patients." Internal Medicine News 40, no. 9 (2007): 37. http://dx.doi.org/10.1016/s1097-8690(07)70526-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

BOSCHERT, SHERRY. "Lidocaine, Nicotine Patches Can Reduce Postoperative Pain." Hospitalist News 1, no. 1 (2008): 10. http://dx.doi.org/10.1016/s1875-9122(08)70018-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Jagadeesan, Jagajeevan, Wee Leon Lam, and Jeyaram Srinivasan. "Nicotine Patches on Patients for Free Flaps." Plastic and Reconstructive Surgery 119, no. 1 (2007): 437–38. http://dx.doi.org/10.1097/01.prs.0000233615.54648.63.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

DeNelsky, G. Y. "Transdermal nicotine patches: How effective are they?" Cleveland Clinic Journal of Medicine 60, no. 3 (1993): 252–53. http://dx.doi.org/10.3949/ccjm.60.3.252.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Griffith, Richard. "Prescribing nicotine patches to children: caution required." Nurse Prescribing 5, no. 3 (2007): 126–28. http://dx.doi.org/10.12968/npre.2007.5.3.23607.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Yoshifuku, Asuka, Yuko Higashi, Shigeto Matsushita, Kazuhiro Kawai, and Takuro Kanekura. "Transdermal nicotine patches for eosinophilic pustular folliculitis." Journal of Dermatology 40, no. 9 (2013): 711–14. http://dx.doi.org/10.1111/1346-8138.12211.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!